In one paragraphArticle in Biological psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
1 author.
Benjamin WolozinDepartment of Pharmacology and Experimental Therapeutics, Neurology and Program in Neuroscience, Boston University School of Medicine, Boston, Massachusetts. Electronic address: bwolozin@bu.edu.
Funding
Capturing the molecular complexity of Alzheimer's disease through the lens of RNA binding proteinsRF1AG056318 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LI, HU, WOLOZIN, BENJAMIN L · 2018 to 2020
$4.4MStress Granules and the Biology of TDP-43R01ES020395 · NIEHS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WOLOZIN, BENJAMIN L · 2012 to 2016
$4.1MSystems-level functional proteomics analysis assemblies in Alzheimer's disease and mouse models of tauopathyRF1AG061706 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI EMILI, ANDREW, WOLOZIN, BENJAMIN L · 2019 to 2019
$3.9MGenetic Modifiers of Protein Interaction Networks in TauopathyR01AG064932 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI EMILI, ANDREW, WOLOZIN, BENJAMIN L · 2019 to 2023
$3.2MRNA binding proteins as novel targets in Alzheimer's diseaseR01AG050471 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WOLOZIN, BENJAMIN L · 2015 to 2019
$2.9MRegulation of APP Processing by PresenilinsR01AG017485 · NIA · LOYOLA UNIVERSITY CHICAGO · PI WOLOZIN, BENJAMIN L · 2001 to 2004
$1.1MRegulation of brain neuroprotection and inflammation by TIA1R21AG059925 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WOLOZIN, BENJAMIN L · 2018 to 2019
$454kNIA NIH HHS RF1 AG056318NIA NIH HHS RF1 AG061706NIEHS NIH HHS R01 ES020395
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Frontotemporal DementiaFrontotemporal Lobar DegenerationSchizophreniaDendritesDNA-Binding ProteinsHumansDNA-Binding Proteins
What OpenQuestion holds
Textmetadata
Read underepoch 390